4.7 Review

Schwann cells: Activated peripheral glia and their role in neuropathic pain

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 21, Issue 5, Pages 522-527

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2006.12.008

Keywords

Schwann cells; cytokines; erythropoietin; EGF receptor family; myelin; neuropathic pain; sensory

Funding

  1. NINDS NIH HHS [R01 NS041983, R01 NS041983-04] Funding Source: Medline

Ask authors/readers for more resources

Schwann cells provide trophic support and in some cases, insulation to axons. After injury, Schwarm cells undergo phenotypic modulation, acquiring the capacity to proliferate, migrate, and secrete soluble mediators that control Wallerian degeneration and regeneration. Amongst the soluble mediators are pro-inflammatory cytokines that function as chemoattractants but also may sensitize nociceptors. At the same time, Schwarm cells produce factors that counterbalance the pro-inflammatory cytokines, including, for example, interleukin-10 and erythropoietin (Epo). Epo and its receptor, EpoR, are up-regulated in Schwann cells after peripheral nerve injury. EpoR-dependent cell signaling may limit production of TNF-alpha by Schwarm cells within the first five days after injury. In addition, EpoR-dependent cell signaling may reduce axonal degeneration and facilitate recovery from chronic pain states. Other novel factors that regulate Schwann cell phenotype in nerve injury have been recently identified, including the low-density lipoprotein receptor related protein (LRP-1). Our recent studies indicate that LRP-1 may be essential for Schwann cell survival after peripheral nerve injury. To analyze the function of specific Schwarm cell gene products in nerve injury and sensory function, conditional gene deletion and expression experiments in mice have been executed using promoters that are selectively activated in myelinating or non-myelinating Schwarm cells. Blocking ErbB receptor-initiated cell-signaling in either myelinating or non-myelinating Schwarm cells results in unique sensory dysfunctions. Data obtained in gene-targeted animals suggest that sensory alterations can result from changes in Schwann cell physiology without profound myelin degeneration or axonopathy. Aberrations in Schwarm cell biology may lie at the foundation of neuropathic pain and represent an exciting target for therapeutic intervention. (c) 2006 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available